Torthaí cuardaigh - M. Yu. Drokov
- 1 - 14 toradh as 14 á dtaispeáint
-
1
Regulatory T-cells and allogeneic hematopoietic stem cell transplantation de réir O. S. Karavaeva, M. Yu. Drokov, E. G. Khamaganova
Foilsithe / Cruthaithe 2022-12-01The article has summarized the available data about regulatory T cells, describing in-detail the stages of their studying, their development, classification, mechanisms of immunosuppression in general terms and also in the context of allogeneic hematopoietic stem cells transplantation. The effect of...
Faigh an téacs iomlán
Alt -
2
Major histocompatibility complex: history of discovery, evolution, structure, significance in transplantation of allogeneic hematopoietic stem cells de réir F. A. Omarova, M. Yu. Drokov, E. G. Khamaganova
Foilsithe / Cruthaithe 2023-06-01Aim. To reveal the significance of the major histocompatibility complex and the human leukocyte antigen evolutionary divergence in transplantation of allogeneic hematopoietic stem cells. The article traces the evolution of the major histocompatibility complex and discusses the reasons for its format...
Faigh an téacs iomlán
Alt -
3
Treatment adherence in patients with blood system diseases and recipients of allogeneic organs and tissues de réir E. I. Kolgaeva, M. Yu. Drokov, D. E. Vybornykh
Foilsithe / Cruthaithe 2023-03-01Since the middle of the last century, medical communities around the world have begun to attach great importance to the study of adherence to treatment in patients with diseases characterized by long-term and complex therapy, many complications and a potentially high risk of death. Treatment adheren...
Faigh an téacs iomlán
Alt -
4
Clinical significance of infections caused by human 6A and 6B herpes viruses in allogeneic hematopoietic stem cells recipients in the post-transplant period de réir I. S. Saydullayeva, T. A. Tupoleva, D. S. Tikhomirov, M. Yu. Drokov
Foilsithe / Cruthaithe 2024-09-01Allogeneic hematopoietic stem cells transplantation is an effective method for the treatment of hematologic malignancies and other blood system diseases. Infections caused by human 6A and 6B herpes viruses are one of the leading causes of complications and mortality in hematology patients after allo...
Faigh an téacs iomlán
Alt -
5
Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation de réir D. S. Dubnyak, N. V. Risinskaya, M. Yu. Drokov, A. B. Sudarikov
Foilsithe / Cruthaithe 2022-12-01Allogeneic hematopoietic stem cells transplantation is one of the effective methods of treating patients with diseases of the blood system.Establishment of complete (100%) donor chimerism is among of the main indicators of successful transplantation in such cases. Monitoring chimerism makes it possi...
Faigh an téacs iomlán
Alt -
6
Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions de réir A. A. Dmitrova, M. Yu. Drokov, T. A. Tupoleva, V. G. Savchenko
Foilsithe / Cruthaithe 2022-06-01Cytomegalovirus infection is one of the critical and life-threatening infectious complications in patients after allogeneic hematopoietic stem cell transplantation. The most significant risk factors for the development of cytomegalovirus infection are cytomegalovirus serostatus of the donor and reci...
Faigh an téacs iomlán
Alt -
7
Graft failure in allogeneic hematopoietic stem cell recipients: diagnosis and treatment de réir U. V. Maslikova, N. N. Popova, M. Yu. Drokov, E. G. Khamaganova
Foilsithe / Cruthaithe 2023-03-01Graft failure is a group of complications after allogeneic hematopoietic stem cell transplantation, which occurs according to different data up to 30%. The group of complications includes primary and secondary graft failure, primary, secondary and transient poor graft function and graft rejection. D...
Faigh an téacs iomlán
Alt -
8
The late outcomes of syngeneic hematopoietic stem cell transplantation in patients with blood disorders de réir A. A. Dmitrova, L. A. Kuz'mina, V. A. Vasil'eva, M. Yu. Drokov, E. N. Parovichnikova
Foilsithe / Cruthaithe 2022-11-01Introduction. Syngeneic hematopoietic stem cell transplantation is a type of allogeneic stem cell transplantation when the donor of stem cells is a genetically identical (monozygotic) twin of the recipient. After this type of transplantation, there is no immunological conflict as the graft versus ho...
Faigh an téacs iomlán
Alt -
9
Cognitive impairment in patients with hematological malignancies at a long-term period after the transplantation of allogeneic hematopoietic stem cells de réir D. E. Vybornykh, S. Yu. Fedorova, S. O. Khrushchev, M. Yu. Drokov, E. G. Gemdzhian, L. A. Kuzmina, E. N. Parovichnikova
Foilsithe / Cruthaithe 2020-04-01A comprehensive assessment of clinical, clinico-psychopathological, neurological, neuropsychological and instrumental examinations in a single study allows for a more detailed study of cognitive impairments in patients with CSC at a long-term period (12-15 months) after the transplantation of alloge...
Faigh an téacs iomlán
Alt -
10
Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation de réir D. E. Vybornykh, S. Yu. Fedorova, S. O. Khrushchev, M. Yu. Drokov, E. G. Gemdzhian, L. A. Kuzmina, E. N. Parovichnikova
Foilsithe / Cruthaithe 2019-07-01The treatment of patients with hematological malignancies is often complicated by a number of negative side effects, which include mental disorders, among which cognitive impairment occupies a special place. Psychopathological, psychological, neuropsychological, neurophysiological and neurovisual me...
Faigh an téacs iomlán
Alt -
11
Probability of allogeneic hematopoietic stem cell transplant failure depending on the recipient's killer immunoglobulin-like receptor genotype de réir U. V. Maslikova, E. G. Khamaganova, M. Yu. Drokov, I. Yu. Urybin, E. D. Mikhaltsova, L. A. Kuzmina, E. N. Parovichnikova
Foilsithe / Cruthaithe 2023-03-01Introduction. Natural killers are the "first line" of antitumor and antiviral protection in the early stages after аllogeneic hematopoietic stem cell transplantation. Quantitative characteristics reach normal values already in the first month after the infusion of blood stem cells to the r...
Faigh an téacs iomlán
Alt -
12
Effect of <i>CTLA4</i> gene polymorphism on relapse probability among patients with acute leukemias after allogenic hematopoietic stem cells transplantation de réir D. S. Romaniuk, A. A. Khmelevskaya, M. Yu. Drokov, N. N. Popova, V. A. Vasilieva, L. A. Kuzmina, G. A. Efimov, E. N. Parovichnikova, V. G. Savchenko
Foilsithe / Cruthaithe 2019-04-01Background. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is being widely applied as a therapy for hematological malignancies. The long-term outcome of allo-HSCT depends directly on the ability of cytotoxic T-lymphocytes to recognize and eliminate the residual tumor. CTLA-4 is one o...
Faigh an téacs iomlán
Alt -
13
Bloodstream infections in different stage of reconstitution after first allogeneic hematopoietic stem cell transplantation de réir M. I. Akhmedov, G. A. Klyasova, E. N. Parovichnikova, L. A. Kuzmina, A. V. Fedorova, V. A. Vasil’eva, M. Yu. Drokov, S. M. Kulikov, V. G. Savchenko
Foilsithe / Cruthaithe 2022-01-01Background. Bloodstream infections (BSI) are common after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The objective of study was to analyze pre- and post-engraftment BSI.Materials and methods. From January 2018 till May 2021242 patients after first allo-HSCT were enrolled in the...
Faigh an téacs iomlán
Alt -
14
Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation de réir E. D. Mikhaltsova, N. N. Popova, M. Yu. Drokov, N. M. Kapranov, Yu. O. Davydova, V. A. Vasilieva, D. S. Dubnyak, U. V. Maslikova, I. V. Galtseva, L. A. Kuzmina, E. N. Parovichnikova, V. G. Savchenko
Foilsithe / Cruthaithe 2021-11-01The graft-versus-host disease (GVHD) is among the most common complications after hematopoietic stem cell transplantation (allo-HSCT). The main tools for GVHD prevention remain calcineurin inhibitors (cyclosporin A, tacrolimus), methotrexate, mycophenolate mofetil. Upon implementation of reduced-int...
Faigh an téacs iomlán
Alt